NeuroAnimation is the first therapy clinically proven to grow the brain by restoring movement, mental clarity, balance, and confidence.

Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...

RPE65-associated retinal degeneration (RPE65-RD) causes severe visual deficits. Gene therapy with AAV2-hRPE65v2 is a breakthrough but it is currently unknown which visual pathways benefit from ...

A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile five years following lenadogene nolparvovec gene therapy in patients with ...

Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the “vertical midline”). Hemianopia severely affects daily activities ...

Learning to read is not easy, but it is made more difficult for a child who cannot see the words and letters on the page correctly. It may not be a problem with their eyes, though. Even children with ...

With a multi-institutional team of engineers, optometrists, vision researchers, sports medicine physicians and biostatisticians, NJIT's Tara Alvarez set out four years ago to gather data that could ...

When we watch someone move, get injured, or express emotion, our brain doesn’t just see it—it partially feels it. Researchers found eight body-like maps in the visual cortex that organize what we see ...

A neuroimaging study published in Psychiatry Research: Neuroimaging has identified hyperactivity in the superior occipital gyrus, a region of the brain’s visual processing network, as a direct ...

The way a brain tumour influences eyesight largely depends on its location and type. Tumours that develop close to the optic nerve or within areas of the brain responsible for processing vision are ...